Leonard L. Mazur - Aug 12, 2024 Form 4/A - Amendment Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Role
Chief Executive Officer, Director
Signature
/s/ Lorna A. Knick, by Power of Attorney
Stock symbol
CTOR
Transactions as of
Aug 12, 2024
Transactions value $
$0
Form type
4/A - Amendment
Date filed
8/30/2024, 04:05 PM
Date Of Original Report
Aug 14, 2024
Previous filing
Aug 12, 2024
Next filing
Sep 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTOR Stock Option (Right to Buy) Award $0 +3.7M $0.00 3.7M Aug 12, 2024 Common Stock 3.7M $2.15 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.
F2 This Form 4 has been amended to correct the amount of option shares held by the Reporting Person.